WallStSmart

Cementos Pacasmayo SAA ADR (CPAC)vsCRH PLC (CRH)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

CRH PLC generates 1618% more annual revenue ($38.63B vs $2.25B). CRH leads profitability with a 9.9% profit margin vs 9.5%. CPAC appears more attractively valued with a PEG of 1.13. CPAC earns a higher WallStSmart Score of 68/100 (B-).

CPAC

Strong Buy

68

out of 100

Grade: B-

Growth: 7.3Profit: 7.0Value: 7.3Quality: 5.0
Piotroski: 5/9Altman Z: 1.59

CRH

Buy

65

out of 100

Grade: C+

Growth: 6.0Profit: 7.0Value: 4.7Quality: 6.5
Piotroski: 4/9Altman Z: 2.17
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CPACUndervalued (+15.7%)

Margin of Safety

+15.7%

Fair Value

$12.91

Current Price

$12.77

$0.14 discount

UndervaluedFair: $12.91Overvalued
CRHSignificantly Overvalued (-42.3%)

Margin of Safety

-42.3%

Fair Value

$60.02

Current Price

$86.54

$26.52 premium

UndervaluedFair: $60.02Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CPAC5 strengths · Avg: 8.4/10
EPS GrowthGrowth
61.5%10/10

Earnings expanding 61.5% YoY

P/E RatioValuation
17.8x8/10

Attractively priced relative to earnings

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Operating MarginProfitability
24.4%8/10

Strong operational efficiency at 24.4%

Revenue GrowthGrowth
15.4%8/10

15.4% revenue growth

CRH3 strengths · Avg: 8.3/10
Market CapQuality
$55.64B9/10

Large-cap with strong market position

P/E RatioValuation
14.8x8/10

Attractively priced relative to earnings

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

Areas to Watch

CPAC3 concerns · Avg: 3.3/10
Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

Market CapQuality
$1.08B3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.033/10

Elevated debt levels

CRH1 concerns · Avg: 4.0/10
PEG RatioValuation
1.534/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CPAC

The strongest argument for CPAC centers on EPS Growth, P/E Ratio, Price/Book. Revenue growth of 15.4% demonstrates continued momentum. PEG of 1.13 suggests the stock is reasonably priced for its growth.

Bull Case : CRH

The strongest argument for CRH centers on Market Cap, P/E Ratio, Price/Book.

Bear Case : CPAC

The primary concerns for CPAC are Altman Z-Score, Market Cap, Debt/Equity.

Bear Case : CRH

The primary concerns for CRH are PEG Ratio.

Key Dynamics to Monitor

CPAC profiles as a growth stock while CRH is a value play — different risk/reward profiles.

CRH carries more volatility with a beta of 1.19 — expect wider price swings.

CPAC is growing revenue faster at 15.4% — sustainability is the question.

CRH generates stronger free cash flow (490M), providing more financial flexibility.

Bottom Line

CPAC scores higher overall (68/100 vs 65/100) and 15.4% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cementos Pacasmayo SAA ADR

BASIC MATERIALS · BUILDING MATERIALS · USA

Cementos Pacasmayo SAA, a cement company, produces, distributes and sells cement and cement-related materials in Peru. The company is headquartered in Lima, Peru.

CRH PLC

BASIC MATERIALS · BUILDING MATERIALS · USA

CRH plc manufactures and distributes construction materials. The company is headquartered in Dublin, Ireland.

Visit Website →

Want to dig deeper into these stocks?